Daniel Speciale is the global corporate controller and chief investor relations officer at Mallinckrodt Pharmaceuticals. He has responsibility for all controllership and investor relations activities for the company, and is a member of Mallinckrodt’s senior leadership team.
Mr. Speciale joined Mallinckrodt in 2013 and has more than 15 years of experience in various accounting and finance roles. Previously, Mr. Speciale held roles of increasing responsibility in the assurance practice of PricewaterhouseCoopers.
Mr. Speciale holds a bachelor’s and master’s degree in accountancy from the Gies College of Business at the University of Illinois at Champaign-Urbana and is a Certified Public Accountant (inactive).